Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase I To determine the maximum tolerated dose (MTD) and RP2D of PD 0332991 in combination with bortezomib and dexamethasone Phase II To evaluate the anti-tumor activity of PD 0332991 in combination with bortezomib and dexamethasone based on ORR as defined by IMWGURC 9
Critère d'inclusion
- Refractory Multiple Myeloma